Alexander Gaber

1.2k total citations
29 papers, 791 citations indexed

About

Alexander Gaber is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alexander Gaber has authored 29 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alexander Gaber's work include Genetic factors in colorectal cancer (6 papers), Esophageal Cancer Research and Treatment (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Alexander Gaber is often cited by papers focused on Genetic factors in colorectal cancer (6 papers), Esophageal Cancer Research and Treatment (4 papers) and Glycosylation and Glycoproteins Research (3 papers). Alexander Gaber collaborates with scholars based in Sweden, Ireland and Finland. Alexander Gaber's co-authors include Karin Jirström, Björn Nodin, Mathias Uhlén, Jakob Eberhard, Sakarias Wangefjord, Anders Bjartell, Jonas Manjer, Charlotta Hedner, Fredrik Pontén and Kajsa Ericson Lindquist and has published in prestigious journals such as PLoS ONE, Cancer Research and British Journal of Cancer.

In The Last Decade

Alexander Gaber

29 papers receiving 778 citations

Peers

Countries citing papers authored by Alexander Gaber

Since Specialization

Citations

This map shows the geographic impact of Alexander Gaber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Gaber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Gaber more than expected).

Fields of papers citing papers by Alexander Gaber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Gaber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Gaber. The network helps show where Alexander Gaber may publish in the future.

Co-authorship network of co-authors of Alexander Gaber

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Gaber. A scholar is included among the top collaborators of Alexander Gaber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Gaber. Alexander Gaber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma 2016 ·Biomarker Research ·David Borg, Charlotta Hedner, Alexander Gaber, Björn Nodin, (unknown), Karin Jirström, Jakob Eberhard, Anders Johnsson	26
2	Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer 2015 ·PLoS ONE ·(unknown), Björn Nodin, Alexander Gaber, Jakob Eberhard, Mathias Uhlén, Karin Jirström, Mats Jerkeman	20
3	S100A9 expressed in ER−PgR− breast cancers induces inflammatory cytokines and is associated with an impaired overall survival 2015 ·British Journal of Cancer ·Caroline Bergenfelz, Alexander Gaber, Roni Allaoui, (unknown), Karin Jirström, Tomas Leanderson, Karin Leandersson	28
4	Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma 2014 ·Journal of Translational Medicine ·Jacob Elebro, Margareta Heby, Alexander Gaber, Björn Nodin, (unknown), (unknown), Mathias Uhlén, Karin Jirström, Jakob Eberhard	41
5	Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer 2014 ·Journal of Ovarian Research ·Jonna Berntsson, Sebastian Lundgren, Björn Nodin, Mathias Uhlén, Alexander Gaber, Karin Jirström	23
6	Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis 2014 ·PLoS ONE ·(unknown), Jacob Elebro, Alexander Gaber, (unknown), Margareta Heby, (unknown), Björn Nodin, Mathias Uhlén, Jakob Eberhard, Karin Jirström	21
7	Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts 2014 ·BMC Urology ·G. Andersson, (unknown), Alexander Gaber, (unknown), Björn Nodin, Mathias Uhlén, Ulrika Segersten, Per‐Uno Malmström, Karin Jirström	17
8	SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma 2014 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Charlotta Hedner, Alexander Gaber, (unknown), Björn Nodin, Mathias Uhlén, Eugenia Kuteeva, Henrik Johannesson, Karin Jirström, Jakob Eberhard	25
9	Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma 2014 ·Journal of Translational Medicine ·(unknown), Alexander Gaber, Charlotta Hedner, Björn Nodin, Mathias Uhlén, Jakob Eberhard, Karin Jirström	38
10	High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death 2014 ·Biomarker Research ·(unknown), Charlotta Hedner, Alexander Gaber, (unknown), Björn Nodin, Mathias Uhlén, Jakob Eberhard, Karin Jirström	29
11	Detecting EGFR alterations in clinical specimens—pitfalls and necessities 2013 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Sofi Isaksson, Pär‐Ola Bendahl, (unknown), Mats Jönsson, (unknown), Alexander Gaber, Karin Jirström, Per Jönsson, Åke Borg, Leif Johansson, Johan Staaf, Maria Planck	7
12	Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer 2012 ·BMC Cancer ·Anna Larsson, (unknown), Alexander Gaber, Björn Nodin, Per Levéen, Göran Jönsson, Mathias Uhlén, Helgi Birgisson, Karin Jirström	37
13	Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study 2012 ·Biology of Sex Differences ·Jenny Brändstedt, Sakarias Wangefjord, Björn Nodin, Alexander Gaber, Jonas Manjer, Karin Jirström	43
14	Effects of radiation therapy on tissue and serum concentrations of tumour associated trypsin inhibitor and their prognostic significance in rectal cancer patients 2011 ·Radiation Oncology ·Alexander Gaber, (unknown), Kristina Hotakainen, Björn Nodin, Ingrid Palmquist, Anders Bjartell, Ulf‐Håkan Stenman, Bengt Jeppsson, Louis Banka Johnson, Karin Jirström	5
15	High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer 2011 ·PROTEOMICS - CLINICAL APPLICATIONS ·(unknown), Donal J. Brennan, (unknown), Jakob Eberhard, Björn Nodin, Alexander Gaber, Fredrik Pontén, Henrik Johannesson, (unknown), Christian Frantz, Sophia Hober, Louis Banka Johnson, Sven Påhlman, Karin Jirström, Mathias Uhlén	43
16	High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression 2011 ·Diagnostic Pathology ·(unknown), Alexander Gaber, David Ulmert, Mathias Uhlén, Anders Bjartell, Karin Jirström	43
17	Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis 2011 ·Modern Pathology ·Anna Dahlman, Elton Rexhepaj, Donal J. Brennan, William M. Gallagher, Alexander Gaber, Anna Lindgren, Karin Jirström, Anders Bjartell	29
18	Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients 2010 ·BMC Cancer ·Alexander Gaber, Björn Nodin, Kristina Hotakainen, Elise Nilsson, Ulf‐Håkan Stenman, Anders Bjartell, Helgi Birgisson, Karin Jirström	28
19	High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer 2009 ·British Journal of Cancer ·Alexander Gaber, Martin Johansson, Ulf‐Håkan Stenman, Kristina Hotakainen, Fredrik Pontén, Bengt Glimelius, Anders Bjartell, Karin Jirström, (unknown)	54
20	HMG‐CoA reductase expression in breast cancer is associated with a less aggressive phenotype and influenced by anthropometric factors 2008 ·International Journal of Cancer ·Signe Borgquist, Soraya Djerbi, Fredrik Pontén, Lola Anagnostaki, (unknown), Alexander Gaber, Jonas Manjer, Göran Landberg, Karin Jirström	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact